|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02393 YESTAR HEALTH
Nominal 
0.059 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 661,614 | -17.570% | 1,490,029 | 2,409,916 | 2,912,733 | 4,293,982 |
| Cost of Sales | (516,810) | -22.737% | (1,223,165) | (2,010,714) | (2,399,951) | (3,585,273) |
| Gross Profit | 144,804 | 8.275% | 266,864 | 399,202 | 512,782 | 708,709 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 7,706 | -59.627% | (77,977) | (156,655) | 38,837 | (142,004) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | 1,083,407 | 24,705 | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 19,731 | |
| Profit / (Loss) before Taxation | 16,333 | -22.783% | (51,819) | 929,643 | 41,040 | (1,107,342) | |
| Taxation | (16,812) | 68.053% | (17,354) | (26,666) | (39,562) | 86,748 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | 536 | (2,749) | -- | |
| Non-controlling Interests | (2,689) | -50.084% | (5,857) | 18,101 | (12,617) | 28,362 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (3,168) | -- | (75,030) | 921,614 | (13,888) | (992,232) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 4,286 | -34.213% | 9,789 | 28,674 | 162,318 | 292,996 |
| Depreciation & Amortisation | 15,526 | -19.304% | 38,167 | 79,715 | 81,010 | 230,776 |
| Directors' Emoluments | -- | -- | -- | 8,487 | 7,062 | 7,371 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified (Modified Report) | Disclaimer |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -0.140 | -- | -3.220 | 39.530 | -0.600 | -42.600 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.134 | 0.005 | 0.165 | (0.039) |
| NBV per share ($) | 0.163 | -- | 0.162 | 0.198 | (0.196) | (0.175) |
| Remarks: | Real time quote last updated: 10/09/2026 11:50 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -3,168 |
| %Change | -- |
| EPS / (LPS) | RMB -0.001 |
| NBV Per Share (¥) | RMB 0.163 |